The New IPO Playbook

Down round IPOs.

The New IPO Playbook

Down round IPOs generated average post listing gains of 450 percent in 2025, proving that pricing discipline at IPO drives real LP distributions.

The most dangerous assumption a founder carries into an IPO is that the company’s last private round valuation represents a floor from which the public offering price should not deviate. That assumption is structurally wrong, and the market has been demonstrating why for three consecutive years.

Late stage private financing rounds completed between 2019 and 2022 were not equity instruments in any conventional sense. They were structured instruments with equity optionality layered on top of a protected debt foundation. Liquidation preferences ranging from one to two times the invested capital, full ratchet antidilution provisions, and participating preferred terms gave investors economic protection that bore no relationship to the headline per share price. A round that implied a $5 billion company valuation on paper was in fact creating a structured position for preferred holders at a price that was economically rational for them but economically detached from the value of the common stock that public market investors would eventually own. The common shareholders, including founders and employees, held residual claims on a company whose headline valuation was largely a function of the structural arrangements made on behalf of the preferred shareholders.

When companies began filing registration statements in 2023 and the years that followed, investment banks repriced the offerings on a common stock basis. The preferred structures were stripped away by the S1 process. What emerged was an IPO price that was frequently lower than the implied per share price of the most recent private round but was the correct price for what was actually being offered: unstructured common equity in a company that had not yet demonstrated its ability to sustain its private round assumptions in a context where public market investors, rather than structured private investors, were setting the clearing price. The market labeled these outcomes down round IPOs, a term that carried a stigma the underlying mechanics did not justify.

By 2025 that stigma had eroded substantially. The IPO market processed 48 listings during the year, with 17 involving unicorn companies. The post listing performance data substantially reframed the conversation about IPO pricing. Published data from PitchBook shows that venture backed offerings averaged post listing gains of 450 percent, compared to 18 percent for private equity backed listings. That differential is not accidental. Venture backed companies that access public markets are typically earlier in their revenue growth trajectories, and public market investors are purchasing a growth story rather than a mature cash flow stream. Companies that priced conservatively and delivered on the forward revenue assumptions embedded in their S1 filings generated the large post listing returns. Companies that attempted to sustain inflated private valuations through the offering process generated the opposite outcome.

The sector mix of the 2025 IPO class reflects the broader concentration of market interest in artificial intelligence and adjacent technology infrastructure. Technology companies accounted for a substantial majority of the listings and of the post listing performance. Healthcare and biotechnology companies, which historically generate a significant share of annual IPO activity, were underrepresented in 2025 relative to long term averages, largely because the regulatory environment for therapeutic development created timeline uncertainty that reduced the predictability institutional investors require when committing capital to a growth story. Companies planning healthcare or consumer listings in 2026 should calibrate their expectations against sector specific performance benchmarks rather than the technology weighted market averages.

The forward pipeline is materially larger. Published projections from PitchBook forecast 68 listings for 2026, a 44.7 percent increase over 2025. That volume reflects the accumulated backlog of companies that deferred going public through 2022, 2023, and 2024 while waiting for conditions that never fully materialized. The deferral had a cost. The PitchBook and NVCA Venture Monitor reports document net negative LP cash flows of nearly $200 billion since the market slowdown began in 2022. That figure represents promised distributions that were not delivered, and it has eroded LP confidence in venture as an asset class in ways that will take years to repair through consistent realized returns.

The regulatory environment for IPO preparation has shifted in ways that reduce friction for prospective issuers. Provisions of the Jumpstart Our Business Startups Act allow emerging growth companies to submit draft S1 filings confidentially with the Securities and Exchange Commission, to conduct investor testing communications with qualified institutional buyers before committing publicly to a listing timeline, and to operate under a streamlined disclosure regime during the transition to full reporting status. These provisions are being used more broadly than at any point since the JOBS Act was enacted in 2012, and the current regulatory posture at the SEC has further reduced compliance burdens that accumulated during the prior regulatory cycle.

The confidential submission process offers a strategic option that most founders and boards do not fully appreciate until after they have used it. A company that submits its draft registration statement confidentially receives Securities and Exchange Commission staff comments on its disclosure, identifies material gaps in its narrative and financial presentation, and negotiates the S1 with regulators without any of that process becoming visible to competitors, activist investors, or potential acquirers who might use the disclosure to their advantage. The public filing is the commitment point, not the starting point. Companies that use confidential submission to iterate on disclosure and build a more defensible narrative before going public have consistently generated better outcomes than those that filed publicly on day one and managed the comment process in the open market.

The S1 registration statement is not primarily a legal disclosure document, though it is that in a formal sense. It is a pricing negotiation conducted in writing in advance of the actual transaction. The assumptions embedded in the forward looking statements and the specificity of the risk factor disclosures signal to institutional investors where management believes the realistic outcomes lie. Issuers who include risk disclosures that contradict the growth narrative in the business section create cognitive dissonance that institutional investors resolve by widening the discount they apply to the offering price. Issuers who include forward looking statements unsupported by actual operating metrics create securities liability exposure and erode institutional credibility when those statements are not met. The discipline required to walk that line accurately is among the most important services that experienced securities counsel provides, and it is one that first time issuers almost universally undervalue until they have completed their first offering.

The bookbuilding process that precedes IPO pricing creates dynamics that diverge substantially from how private rounds are negotiated. Investment banks assemble institutional indications of interest, price the offering at a level that generates oversubscription in the range of three to eight times the offered amount, and allocate shares to institutional investors who are expected to provide price support in the early days of trading. That expectation is an informal market convention, not a binding contractual obligation. The result is the pattern documented in the 2025 data: 65 percent of listings showed gains on the first trading day, but only 41 percent were trading above their listing price at year end. The institutional book created apparent demand that was not durable when measured over the full holding period of a typical long term investor.

The companies that generated sustained post listing performance in 2025 were not simply those that priced correctly at the offering. They were the ones that actively managed the transition from IPO book investors to long term holders. That management process involves initiating equity research analyst coverage, presenting at institutional investor conferences in the weeks after listing, communicating formally with indexed fund investors who allocate based on index inclusion criteria, and organizing investor day presentations that translate the S1 story into a detailed operational narrative that analysts can use to build and maintain financial models. Treating the IPO as a discrete transaction rather than the opening of an ongoing capital markets relationship is the single most common error made by founders accessing public markets for the first time.

The lockup expiration period, standardly set at 90 to 180 days after listing, is the first real test of the post listing shareholder base. At lockup expiration, insiders, early employees, and pre IPO investors gain the ability to sell shares into the public market. The supply of shares available for sale typically exceeds institutional demand capacity unless the company has actively built offsetting buying interest through its investor relations program. Companies that have met or exceeded the revenue projections in their S1, built analyst consensus support, and established relationships with long term institutional holders enter the lockup expiration with materially better demand dynamics than those that have not. The lockup expiration should be planned for and prepared for with the same rigor as the offering itself.

The unexpected implication of the new IPO playbook challenges the conventional relationship between the investment bank and the issuer. The bank is compensated primarily on the basis of the offering amount and the opening day performance, which creates incentives aligned with a successful transaction rather than a successfully transitioned public company. Founders and boards that treat the investment bank as an advisor rather than as an agent with potentially divergent economic interests are better positioned to manage the post listing period on their own terms. The companies generating real post listing returns in 2026 will be those that internalized the lesson the 2025 data makes available: realistic pricing at listing combined with disciplined post listing investor management outperforms optimistic pricing combined with passive post listing management in every market condition that does not involve the kind of once in a generation liquidity environment that no longer exists. The open question for the 2026 pipeline is how many companies have genuinely internalized that lesson, and how many believe they will be the exception to a pattern that the data has now documented at scale.

One additional dimension of the 2026 IPO environment that founders and boards rarely model explicitly is the role of index inclusion in generating sustained post listing demand. When a company lists on a major exchange and meets the criteria for inclusion in an equity index, passive investment funds and exchange traded funds that track that index are required to purchase shares of the newly listed company. That mandatory buying creates structural demand that is independent of the company’s operating performance in the weeks after listing. Companies that understand the index inclusion timeline, the float requirements, and the market capitalization thresholds that determine when and how they qualify for index inclusion can use that knowledge to anticipate demand pockets in the post listing period and time their investor relations activities accordingly.

The practical preparation required to take advantage of the new IPO environment begins before the formal decision to go public is made. Companies that have maintained audited financial statements, built a board with independent directors, established a disclosure controls and procedures framework, and organized their equity capitalization for public company administration are in a fundamentally different position from those that begin that work after deciding to file. The cost of preparation done in advance is a fixed cost that the company bears whether or not it ultimately lists. The cost of preparation deferred until after the filing decision is made is a variable cost that accumulates daily and often forces companies to accept advisory relationships, audit firms, and legal counsel chosen under time pressure rather than based on fit. The firms generating the best IPO outcomes in 2026 began their preparation in 2024 or earlier.